WDR77 and prostate carcinoma: Notably, in endocrine-related cancers, such as breast cancer, ovarian epithelial tumors, endometrial cancer, adrenocortical carcinoma, and prostate cancer, we find frequent amplification of the MEP50 locus (Supplementary Fig. S1B).